Page last updated: 2024-11-04

sulfamethoxazole and Campylobacter Infection

sulfamethoxazole has been researched along with Campylobacter Infection in 2 studies

Sulfamethoxazole: A bacteriostatic antibacterial agent that interferes with folic acid synthesis in susceptible bacteria. Its broad spectrum of activity has been limited by the development of resistance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p208)
sulfamethoxazole : An isoxazole (1,2-oxazole) compound having a methyl substituent at the 5-position and a 4-aminobenzenesulfonamido group at the 3-position.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Hagos, Y1
Gugsa, G1
Awol, N1
Ahmed, M1
Tsegaye, Y1
Abebe, N1
Bsrat, A1
Williams, MD1
Schorling, JB1
Barrett, LJ1
Dudley, SM1
Orgel, I1
Koch, WC1
Shields, DS1
Thorson, SM1
Lohr, JA1
Guerrant, RL1

Other Studies

2 other studies available for sulfamethoxazole and Campylobacter Infection

ArticleYear
Isolation, identification, and antimicrobial susceptibility pattern of Campylobacter jejuni and Campylobacter coli from cattle, goat, and chicken meats in Mekelle, Ethiopia.
    PloS one, 2021, Volume: 16, Issue:2

    Topics: Amoxicillin; Ampicillin; Animals; Anti-Bacterial Agents; Campylobacter coli; Campylobacter Infection

2021
Early treatment of Campylobacter jejuni enteritis.
    Antimicrobial agents and chemotherapy, 1989, Volume: 33, Issue:2

    Topics: Adult; Campylobacter fetus; Campylobacter Infections; Child; Drug Combinations; Enteritis; Erythromy

1989